A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

NCT04850118 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

X-Linked Retinitis Pigmentosa

Interventions

BIOLOGICAL: rAAV2tYF-GRK1-hRPGRco
DRUG: Control

Sponsor

Beacon Therapeutics